IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

IRLAB Therapeutics AB Employees

IRLAB Therapeutics AB had 31 employees as of March 31, 2026. The number of employees increased by 1 or 3.33% compared to the same quarter last year.

• Employees: 31
• Change: 1
• Growth: 3.33%
• Revenue / Employee: 2.98M SEK
• Profits / Employee: -2.16M SEK
• Market Cap: 107.70M

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2026	31	1	3.33%
Dec 31, 2025	31	0	-
Sep 30, 2025	31	-1	-3.13%
Jun 30, 2025	30	-2	-6.25%
Mar 31, 2025	30	-2	-6.25%
Dec 31, 2024	31	-3	-8.82%
Sep 30, 2024	32	1	3.23%
Jun 30, 2024	32	1	3.23%
Mar 31, 2024	32	1	3.23%
Dec 31, 2023	34	3	9.68%
Sep 30, 2023	31	0	-
Jun 30, 2023	31	3	10.71%
Mar 31, 2023	31	7	29.17%
Sep 30, 2022	31	3	10.71%
Jun 30, 2022	28	1	3.70%
Mar 31, 2022	24	-1	-4.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error